Kiniksa Pharmaceuticals International (KNSA) Earnings Date & Reports

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

KNSA is expected to report earnings to rise 60.82% to 17 cents per share on July 29

Kiniksa Pharmaceuticals International KNSA Stock Earnings Reports

Q2'25

Est.

$0.18

Q1'25

Beat

by $0.09

Q4'24

Missed

by $0.14

Q3'24

Missed

by $0.19

Q2'24

Beat

by $0.02

The last earnings report on April 29 showed earnings per share of 10 cents, beating the estimate of 1 cents. With 662.35K shares outstanding, the current market capitalization sits at 2.02B.

View a ticker or compare two or three

Compare

KNSA